1,8-Diamino-6-ethoxy-3-morpholin-4-yl-2,7-naphthyridine-4-carbonitrile

Catalog No. :
ACTYIW540
CAS No. :
459153-40-3
Molecular Formula :
C15H18N6O2
Molecular Weight :
314.35

IUPAC Name:1,8-diamino-6-ethoxy-3-morpholino-2,7-naphthyridine-4-carbonitrile

1,8-Diamino-6-ethoxy-3-morpholin-4-yl-2,7-naphthyridine-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$447.00Login to see priceInquiryInquiry
5g98%$1299.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,8-Diamino-6-ethoxy-3-morpholin-4-yl-2,7-naphthyridine-4-carbonitrile
IUPAC Name1,8-diamino-6-ethoxy-3-morpholino-2,7-naphthyridine-4-carbonitrile
MDL No.MFCD02348577
Molecular FormulaC15H18N6O2
Molecular Weight314.35
SMILESN#CC1=C(N2CCOCC2)N=C(N)C3=C1C=C(OCC)N=C3N
InChI KeyVCNJIYWLMVPTHX-UHFFFAOYSA-N
Synonym2,7-Naphthyridine-4-carbonitrile, 1,8-diamino-6-ethoxy-3-(4-morpholinyl)-;1,8-Diamino-6-ethoxy-3-morpholino-2,7-naphthyridine-4-carbonitrile
CAS No.459153-40-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTYIW540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTYIW540 route product structure diagram
    ACTYIW540459153-40-3
Inquiry

2. ACTYIW540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTYIW540 route product structure diagram
    ACTYIW540459153-40-3
Inquiry

Comments (0)